发明名称 |
Selective Chemokine Modulation |
摘要 |
A method of treating or preventing a disease characterized by adverse expression and/or release of 10 kDa interferon-γ inducible protein, IP-10, comprises administering granules or particles made of a metal or an oxide of a metal to a subject suffering from the disease. A method of reducing IP-10 in a subject suffering from a disease characterized by adverse expression and/or release of IP-10 comprises administering granules or particles made of a metal or an oxide of a metal to the subject. The metal is a metal of group 4 or 5 of the periodic table of the elements and selected from the group consisting of titanium, zirconium, hafnium, niobium and tantalum. |
申请公布号 |
US2014302149(A1) |
申请公布日期 |
2014.10.09 |
申请号 |
US201414312571 |
申请日期 |
2014.06.23 |
申请人 |
Prophy Med AB |
发明人 |
Bruce Lars;Lyngstadaas Staale Petter |
分类号 |
A61K33/24;A61K9/14 |
主分类号 |
A61K33/24 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating or preventing a disease characterized by adverse expression and/or release of 10 kDa interferon-γ inducible protein, IP-10, said method comprising administering granules or particles made of a metal or an oxide of a metal to a subject suffering from said disease, wherein said metal is a metal of group 4 or 5 of the periodic table of the elements and selected from the group consisting of titanium, zirconium, hafnium, niobium and tantalum. |
地址 |
Viken SE |